IMPECS
The IMPECS (Impact de l'environnement chimique sur la santé) research unit is a multi-disciplinary team whose aim is to gain a better understanding of the reaction complexity of lung tissue exposed to chemical compounds in the air we breathe, to explain inequalities between individuals with regard to these substances, to gain a better understanding of risk levels and, consequently, to better prevent risks and limit the impact of this environment on respiratory health. Our research unit brings together toxicologists, epidemiologists, physicians and pharmacists, divided into two research areas:
Axis 1: Mechanisms of toxic action of air contaminants: In vivo and in vitro experimental approaches to analyze the pneumotoxicity of air contaminants and identify biomarkers of effect.
Area 2: Human biomonitoring: Research and validation in humans of biomarkers of exposure, impregnation and early effects of aerocontaminants.
CLiMe: Innovation in clinical metabolomics at the University of Liège
The Clinical Metabolomics Group (CliMe) at the University of Liège is the result of a strategic collaboration between the Department of Clinical Chemistry at the University Hospital and the University of Liège, and the Metabolomics Group of the Interdisciplinary Center for Drug Research (CIRM) at the University of Liège. Responding to growing demand for advanced metabolomic analyses, CliMe merges clinical and preclinical research with everyday medical practice.
Drawing on the expertise of the Clinical Chemistry Laboratory in biomarker validation and mass spectrometry, as well as the competence of CIRM's Metabolomics Group in NMR, CliMe is committed to being at the heart of innovation for precise, personalized medicine. This interdisciplinary team boasts a state-of-the-art analytical platform, equipped with high-resolution mass spectrometers and sophisticated NMR systems, backed by in-depth expertise in biological sample preparation and metabolomics data analysis.